25 XP   0   0   10

Axonics Inc
Buy, Hold or Sell?

Let's analyse Axonics together

PenkeI guess you are interested in Axonics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Axonics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Axonics Inc

I send you an email if I find something interesting about Axonics Inc.

Quick analysis of Axonics (30 sec.)










What can you expect buying and holding a share of Axonics? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€11.75
Expected worth in 1 year
€12.99
How sure are you?
61.1%

+ What do you gain per year?

Total Gains per Share
€1.24
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
€62.50
Expected price per share
€60.50 - €63.50
How sure are you?
50%

1. Valuation of Axonics (5 min.)




Live pricePrice per Share (EOD)

€62.50

Intrinsic Value Per Share

€26.38 - €31.93

Total Value Per Share

€38.13 - €43.68

2. Growth of Axonics (5 min.)




Is Axonics growing?

Current yearPrevious yearGrowGrow %
How rich?$637.5m$505.2m$101.1m16.7%

How much money is Axonics making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$14.9m$13.4m880.6%
Net Profit Margin-2.7%-25.1%--

How much money comes from the company's main activities?

3. Financial Health of Axonics (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Axonics? (5 min.)

Welcome investor! Axonics's management wants to use your money to grow the business. In return you get a share of Axonics.

What can you expect buying and holding a share of Axonics?

First you should know what it really means to hold a share of Axonics. And how you can make/lose money.

Speculation

The Price per Share of Axonics is €62.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Axonics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Axonics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.75. Based on the TTM, the Book Value Change Per Share is €0.31 per quarter. Based on the YOY, the Book Value Change Per Share is €0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Axonics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.130.2%0.090.1%-0.29-0.5%-0.24-0.4%-0.24-0.4%
Usd Book Value Change Per Share0.530.8%0.330.5%0.430.7%0.691.1%0.691.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.530.8%0.330.5%0.430.7%0.691.1%0.691.1%
Usd Price Per Share60.66-54.43-63.19-48.98-48.98-
Price to Earnings Ratio117.65-156.88-264.35-75.70-75.70-
Price-to-Total Gains Ratio114.82-228.96--20.72--34.50--34.50-
Price to Book Ratio4.85-4.57-6.40-6.57-6.57-
Price-to-Total Gains Ratio114.82-228.96--20.72--34.50--34.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share66.5125
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.330.69
Usd Total Gains Per Share0.330.69
Gains per Quarter (15 shares)4.9610.42
Gains per Year (15 shares)19.8341.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10201004232
20403008374
3059500125116
4079700167158
5099900208200
601191100250242
701391300292284
801591500333326
901781700375368
1001981900417410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%5.07.00.041.7%5.013.00.027.8%5.013.00.027.8%5.013.00.027.8%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%11.07.00.061.1%11.07.00.061.1%11.07.00.061.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%11.07.00.061.1%11.07.00.061.1%11.07.00.061.1%

Fundamentals of Axonics

About Axonics Inc

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Fundamental data was last updated by Penke on 2024-04-05 06:30:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Axonics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Axonics earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Net Profit Margin of 6.0% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Axonics Inc:

  • The MRQ is 6.0%. The company is making a profit. +1
  • The TTM is -2.7%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM-2.7%+8.7%
TTM-2.7%YOY-25.1%+22.4%
TTM-2.7%5Y-148.9%+146.2%
5Y-148.9%10Y-148.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%-11.2%+17.2%
TTM-2.7%-19.6%+16.9%
YOY-25.1%-14.4%-10.7%
5Y-148.9%-21.3%-127.6%
10Y-148.9%-24.8%-124.1%
1.1.2. Return on Assets

Shows how efficient Axonics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • 0.9% Return on Assets means that Axonics generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Axonics Inc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-0.3%+1.2%
TTM-0.3%YOY-2.7%+2.5%
TTM-0.3%5Y-4.2%+4.0%
5Y-4.2%10Y-4.2%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%-4.0%+4.9%
TTM-0.3%-4.5%+4.2%
YOY-2.7%-4.8%+2.1%
5Y-4.2%-4.0%-0.2%
10Y-4.2%-5.2%+1.0%
1.1.3. Return on Equity

Shows how efficient Axonics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • 1.0% Return on Equity means Axonics generated €0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Axonics Inc:

  • The MRQ is 1.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.0%TTM-0.3%+1.3%
TTM-0.3%YOY-3.2%+2.9%
TTM-0.3%5Y-5.2%+4.9%
5Y-5.2%10Y-5.2%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%-3.9%+4.9%
TTM-0.3%-5.6%+5.3%
YOY-3.2%-5.9%+2.7%
5Y-5.2%-6.1%+0.9%
10Y-5.2%-7.1%+1.9%

1.2. Operating Efficiency of Axonics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Axonics is operating .

  • Measures how much profit Axonics makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Axonics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.1%+0.1%
TTM-0.1%YOY-18.7%+18.6%
TTM-0.1%5Y-140.2%+140.1%
5Y-140.2%10Y-140.2%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--21.4%+21.4%
TTM-0.1%-18.0%+17.9%
YOY-18.7%-13.7%-5.0%
5Y-140.2%-19.2%-121.0%
10Y-140.2%-24.0%-116.2%
1.2.2. Operating Ratio

Measures how efficient Axonics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.20 means that the operating costs are €1.20 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Axonics Inc:

  • The MRQ is 1.204. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.276. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.204TTM1.276-0.073
TTM1.276YOY1.469-0.193
TTM1.2765Y2.800-1.523
5Y2.80010Y2.8000.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2041.428-0.224
TTM1.2761.433-0.157
YOY1.4691.431+0.038
5Y2.8001.440+1.360
10Y2.8001.382+1.418

1.3. Liquidity of Axonics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Axonics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 10.73 means the company has €10.73 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Axonics Inc:

  • The MRQ is 10.726. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.343. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.726TTM11.343-0.617
TTM11.343YOY9.262+2.082
TTM11.3435Y10.641+0.703
5Y10.64110Y10.6410.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7262.787+7.939
TTM11.3432.763+8.580
YOY9.2623.488+5.774
5Y10.6413.617+7.024
10Y10.6413.537+7.104
1.3.2. Quick Ratio

Measures if Axonics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Quick Ratio of 6.49 means the company can pay off €6.49 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Axonics Inc:

  • The MRQ is 6.491. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.767. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.491TTM5.767+0.724
TTM5.767YOY1.878+3.889
TTM5.7675Y2.250+3.518
5Y2.25010Y2.2500.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4911.539+4.952
TTM5.7671.656+4.111
YOY1.8782.113-0.235
5Y2.2502.289-0.039
10Y2.2502.256-0.006

1.4. Solvency of Axonics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Axonics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Axonics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.11 means that Axonics assets are financed with 11.4% credit (debt) and the remaining percentage (100% - 11.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Axonics Inc:

  • The MRQ is 0.114. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.100. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.100+0.015
TTM0.100YOY0.133-0.034
TTM0.1005Y0.147-0.047
5Y0.14710Y0.1470.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1140.389-0.275
TTM0.1000.386-0.286
YOY0.1330.347-0.214
5Y0.1470.442-0.295
10Y0.1470.460-0.313
1.4.2. Debt to Equity Ratio

Measures if Axonics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 12.9% means that company has €0.13 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Axonics Inc:

  • The MRQ is 0.129. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.112. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.112+0.018
TTM0.112YOY0.154-0.042
TTM0.1125Y0.177-0.065
5Y0.17710Y0.1770.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.559-0.430
TTM0.1120.560-0.448
YOY0.1540.478-0.324
5Y0.1770.624-0.447
10Y0.1770.674-0.497

2. Market Valuation of Axonics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Axonics generates.

  • Above 15 is considered overpriced but always compare Axonics to the Medical Devices industry mean.
  • A PE ratio of 117.65 means the investor is paying €117.65 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Axonics Inc:

  • The EOD is 129.003. Based on the earnings, the company is expensive. -2
  • The MRQ is 117.651. Based on the earnings, the company is expensive. -2
  • The TTM is 156.882. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD129.003MRQ117.651+11.352
MRQ117.651TTM156.882-39.231
TTM156.882YOY264.353-107.471
TTM156.8825Y75.696+81.185
5Y75.69610Y75.6960.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD129.003-1.067+130.070
MRQ117.651-1.578+119.229
TTM156.882-2.341+159.223
YOY264.353-2.969+267.322
5Y75.696-2.081+77.777
10Y75.696-1.463+77.159
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Axonics Inc:

  • The EOD is 196.175. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 178.912. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -53.029. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD196.175MRQ178.912+17.263
MRQ178.912TTM-53.029+231.941
TTM-53.029YOY-37.354-15.674
TTM-53.0295Y-45.864-7.165
5Y-45.86410Y-45.8640.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD196.175-1.015+197.190
MRQ178.912-1.544+180.456
TTM-53.029-2.914-50.115
YOY-37.354-6.192-31.162
5Y-45.864-4.771-41.093
10Y-45.864-5.214-40.650
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Axonics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.85 means the investor is paying €4.85 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Axonics Inc:

  • The EOD is 5.321. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.852. Based on the equity, the company is fair priced.
  • The TTM is 4.574. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.321MRQ4.852+0.468
MRQ4.852TTM4.574+0.278
TTM4.574YOY6.402-1.828
TTM4.5745Y6.568-1.993
5Y6.56810Y6.5680.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.3212.021+3.300
MRQ4.8522.379+2.473
TTM4.5742.465+2.109
YOY6.4023.219+3.183
5Y6.5683.798+2.770
10Y6.5684.163+2.405
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Axonics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4960.311+60%0.404+23%0.653-24%0.653-24%
Book Value Per Share--11.74711.171+5%9.308+26%7.759+51%7.759+51%
Current Ratio--10.72611.343-5%9.262+16%10.641+1%10.641+1%
Debt To Asset Ratio--0.1140.100+15%0.133-14%0.147-22%0.147-22%
Debt To Equity Ratio--0.1290.112+16%0.154-16%0.177-27%0.177-27%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1210.085+43%-0.275+327%-0.229+289%-0.229+289%
Free Cash Flow Per Share--0.080-0.026+132%0.004+1686%-0.162+304%-0.162+304%
Free Cash Flow To Equity Per Share--0.090-0.006+107%0.622-85%0.359-75%0.359-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--31.931--------
Intrinsic Value_10Y_min--26.379--------
Intrinsic Value_1Y_max--0.179--------
Intrinsic Value_1Y_min--0.174--------
Intrinsic Value_3Y_max--2.840--------
Intrinsic Value_3Y_min--2.665--------
Intrinsic Value_5Y_max--8.276--------
Intrinsic Value_5Y_min--7.483--------
Market Cap3187712500.000+9%2907193800.0002608823910.000+11%3028326875.000-4%2347289808.889+24%2347289808.889+24%
Net Profit Margin--0.060-0.027+145%-0.251+518%-1.489+2585%-1.489+2585%
Operating Margin----0.0010%-0.1870%-1.4020%-1.4020%
Operating Ratio--1.2041.276-6%1.469-18%2.800-57%2.800-57%
Pb Ratio5.321+9%4.8524.574+6%6.402-24%6.568-26%6.568-26%
Pe Ratio129.003+9%117.651156.882-25%264.353-55%75.696+55%75.696+55%
Price Per Share62.500+9%57.00051.150+11%59.375-4%46.022+24%46.022+24%
Price To Free Cash Flow Ratio196.175+9%178.912-53.029+130%-37.354+121%-45.864+126%-45.864+126%
Price To Total Gains Ratio125.901+9%114.821228.955-50%-20.724+118%-34.495+130%-34.495+130%
Quick Ratio--6.4915.767+13%1.878+246%2.250+189%2.250+189%
Return On Assets--0.009-0.003+128%-0.027+400%-0.042+561%-0.042+561%
Return On Equity--0.010-0.003+128%-0.032+406%-0.052+606%-0.052+606%
Total Gains Per Share--0.4960.311+60%0.404+23%0.653-24%0.653-24%
Usd Book Value--637582323.589606347175.917+5%505218269.556+26%421118324.815+51%421118324.815+51%
Usd Book Value Change Per Share--0.5280.331+60%0.430+23%0.694-24%0.694-24%
Usd Book Value Per Share--12.50111.888+5%9.906+26%8.257+51%8.257+51%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1290.090+43%-0.293+327%-0.244+289%-0.244+289%
Usd Free Cash Flow--4323124.243-1391539.992+132%242006.955+1686%-7824947.105+281%-7824947.105+281%
Usd Free Cash Flow Per Share--0.085-0.027+132%0.005+1686%-0.173+304%-0.173+304%
Usd Free Cash Flow To Equity Per Share--0.096-0.006+107%0.661-85%0.382-75%0.382-75%
Usd Market Cap3392363642.500+9%3093835641.9602776310405.022+11%3222745460.375-4%2497985814.620+24%2497985814.620+24%
Usd Price Per Share66.513+9%60.65954.434+11%63.187-4%48.977+24%48.977+24%
Usd Profit--6574188.937-1522043.742+123%-14924928.930+327%-13807341.256+310%-13807341.256+310%
Usd Revenue--109738153.78491597382.433+20%68427466.549+60%52399339.247+109%52399339.247+109%
Usd Total Gains Per Share--0.5280.331+60%0.430+23%0.694-24%0.694-24%
 EOD+4 -4MRQTTM+25 -7YOY+26 -65Y+23 -910Y+23 -9

3.2. Fundamental Score

Let's check the fundamental score of Axonics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15129.003
Price to Book Ratio (EOD)Between0-15.321
Net Profit Margin (MRQ)Greater than00.060
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.491
Current Ratio (MRQ)Greater than110.726
Debt to Asset Ratio (MRQ)Less than10.114
Debt to Equity Ratio (MRQ)Less than10.129
Return on Equity (MRQ)Greater than0.150.010
Return on Assets (MRQ)Greater than0.050.009
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Axonics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.896
Ma 20Greater thanMa 5062.350
Ma 50Greater thanMa 10061.860
Ma 100Greater thanMa 20057.070
OpenGreater thanClose62.000
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets719,923
Total Liabilities82,359
Total Stockholder Equity637,564
 As reported
Total Liabilities 82,359
Total Stockholder Equity+ 637,564
Total Assets = 719,923

Assets

Total Assets719,923
Total Current Assets491,422
Long-term Assets228,501
Total Current Assets
Cash And Cash Equivalents 104,811
Short-term Investments 240,149
Net Receivables 57,243
Inventory 79,940
Other Current Assets 9,279
Total Current Assets  (as reported)491,422
Total Current Assets  (calculated)491,422
+/-0
Long-term Assets
Property Plant Equipment 10,760
Goodwill 99,417
Intangible Assets 81,375
Long-term Assets Other 36,949
Long-term Assets  (as reported)228,501
Long-term Assets  (calculated)228,501
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities45,816
Long-term Liabilities36,543
Total Stockholder Equity637,564
Total Current Liabilities
Accounts payable 18,452
Total Current Liabilities  (as reported)45,816
Total Current Liabilities  (calculated)18,452
+/- 27,364
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt27,617
Long-term Liabilities  (as reported)36,543
Long-term Liabilities  (calculated)27,617
+/- 8,926
Total Stockholder Equity
Total Stockholder Equity (as reported)637,564
Total Stockholder Equity (calculated)0
+/- 637,564
Other
Capital Stock5
Common Stock Shares Outstanding 50,771
Net Invested Capital 637,564
Net Working Capital 445,606
Property Plant and Equipment Gross 21,625



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
126,044
219,822
217,379
348,736
347,671
342,206
444,970
565,512
561,305
547,945
525,571
514,088
632,278
659,353
665,691
648,985
660,747
719,923
719,923660,747648,985665,691659,353632,278514,088525,571547,945561,305565,512444,970342,206347,671348,736217,379219,822126,044
   > Total Current Assets 
117,824
211,680
204,065
335,505
334,458
327,946
228,372
332,183
330,229
321,317
307,433
313,127
449,361
465,075
469,671
455,396
475,385
491,422
491,422475,385455,396469,671465,075449,361313,127307,433321,317330,229332,183228,372327,946334,458335,505204,065211,680117,824
       Cash And Cash Equivalents 
76,231
171,082
159,820
287,679
269,280
241,181
130,962
231,140
228,797
220,878
213,180
203,236
241,331
238,846
240,105
145,343
147,323
104,811
104,811147,323145,343240,105238,846241,331203,236213,180220,878228,797231,140130,962241,181269,280287,679159,820171,08276,231
       Short-term Investments 
25,311
12,592
0
0
0
0
0
0
0
0
0
9,998
108,682
118,365
116,957
186,173
197,393
240,149
240,149197,393186,173116,957118,365108,6829,99800000000012,59225,311
       Net Receivables 
954
8,779
21,670
15,015
18,550
18,270
21,509
25,646
26,641
29,044
27,425
36,115
36,960
44,817
40,200
47,436
48,944
57,243
57,24348,94447,43640,20044,81736,96036,11527,42529,04426,64125,64621,50918,27018,55015,01521,6708,779954
       Inventory 
12,703
15,659
19,230
30,138
44,308
63,060
71,243
70,391
70,358
64,946
61,876
58,412
57,827
55,765
66,067
70,083
74,909
79,940
79,94074,90970,08366,06755,76557,82758,41261,87664,94670,35870,39171,24363,06044,30830,13819,23015,65912,703
   > Long-term Assets 
8,220
8,142
13,314
13,231
13,213
14,260
216,598
233,329
231,076
226,628
218,138
200,961
182,917
194,278
196,020
193,589
185,362
228,501
228,501185,362193,589196,020194,278182,917200,961218,138226,628231,076233,329216,59814,26013,21313,23113,3148,1428,220
       Property Plant Equipment 
0
7,247
6,106
12,362
12,392
13,428
12,948
12,658
12,568
14,015
13,707
13,828
7,103
6,798
7,017
6,349
6,556
10,760
10,7606,5566,3497,0176,7987,10313,82813,70714,01512,56812,65812,94813,42812,39212,3626,1067,2470
       Goodwill 
0
0
0
0
0
0
87,382
106,631
109,565
105,510
102,558
94,852
86,942
94,414
96,581
98,880
95,287
99,417
99,41795,28798,88096,58194,41486,94294,852102,558105,510109,565106,63187,382000000
       Intangible Assets 
0
0
282
0
0
0
115,023
113,416
108,302
106,469
101,179
91,627
81,787
86,253
85,888
85,543
80,274
81,375
81,37580,27485,54385,88886,25381,78791,627101,179106,469108,302113,416115,02300028200
       Long-term Assets Other 
4,928
4,784
7,626
7,415
7,196
7,736
8,145
7,324
7,041
7,734
7,494
7,254
7,085
6,813
6,534
2,817
3,245
36,949
36,9493,2452,8176,5346,8137,0857,2547,4947,7347,0417,3248,1457,7367,1967,4157,6264,7844,928
> Total Liabilities 
33,856
36,819
44,903
50,840
53,773
54,836
114,816
61,247
71,215
65,507
62,139
76,362
82,760
89,214
89,085
48,456
50,127
82,359
82,35950,12748,45689,08589,21482,76076,36262,13965,50771,21561,247114,81654,83653,77350,84044,90336,81933,856
   > Total Current Liabilities 
15,543
12,033
19,847
30,829
38,816
45,682
24,046
24,387
27,751
26,868
25,519
29,859
60,843
65,247
66,170
32,084
35,593
45,816
45,81635,59332,08466,17065,24760,84329,85925,51926,86827,75124,38724,04645,68238,81630,82919,84712,03315,543
       Short Long Term Debt 
6,382
0
5,000
10,000
15,000
21,110
22
30
109
0
0
0
0
32,600
0
0
0
0
000032,6000000109302221,11015,00010,0005,00006,382
       Accounts payable 
4,232
5,882
7,440
10,728
9,415
10,660
11,446
9,447
10,512
7,654
10,390
10,207
9,972
9,070
14,737
12,185
14,666
18,452
18,45214,66612,18514,7379,0709,97210,20710,3907,65410,5129,44711,44610,6609,41510,7287,4405,8824,232
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
30,500
32,600
34,400
0
0
0
00034,40032,60030,500000000000000
   > Long-term Liabilities 
18,313
24,786
25,056
20,011
14,957
9,154
90,770
36,860
43,464
38,639
36,620
46,503
21,917
23,967
22,915
16,372
14,534
36,543
36,54314,53416,37222,91523,96721,91746,50336,62038,63943,46436,86090,7709,15414,95720,01125,05624,78618,313
       Long term Debt 
13,740
20,336
15,571
10,750
5,930
0
75,171
89
0
0
0
0
0
0
0
0
0
0
00000000008975,17105,93010,75015,57120,33613,740
       Capital Lease Obligations Min Short Term Debt
5,198
5,052
10,279
10,112
9,935
10,434
10,211
9,888
9,553
10,418
10,089
9,750
9,483
9,117
8,735
2,968
2,847
27,617
27,6172,8472,9688,7359,1179,4839,75010,08910,4189,5539,88810,21110,4349,93510,11210,2795,0525,198
       Other Liabilities 
0
0
0
0
0
0
6,750
28,290
35,312
29,587
27,934
38,182
13,957
16,412
0
0
13,658
0
013,6580016,41213,95738,18227,93429,58735,31228,2906,750000000
       Long-term Liabilities Other 
0
0
0
0
0
0
6,750
7,664
8,880
10,370
10,370
22,400
0
0
0
0
0
0
00000022,40010,37010,3708,8807,6646,750000000
> Total Stockholder Equity
92,188
183,003
172,476
297,896
293,898
287,370
330,154
504,265
490,090
482,438
463,432
437,726
549,518
570,139
576,606
600,529
610,620
637,564
637,564610,620600,529576,606570,139549,518437,726463,432482,438490,090504,265330,154287,370293,898297,896172,476183,00392,188
   Common Stock
0
3
3
4
4
4
4
5
5
5
5
5
5
5
0
0
5
0
050055555554444330
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 0-24,51100-25,147-36,185-24,128-11,480-6,560-6,912-1,774-2,633-431-614-713-605-4280



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue366,379
Cost of Revenue-91,825
Gross Profit274,554274,554
 
Operating Income (+$)
Gross Profit274,554
Operating Expense-371,091
Operating Income-4,712-96,537
 
Operating Expense (+$)
Research Development34,886
Selling General Administrative235,316
Selling And Marketing Expenses-
Operating Expense371,091270,202
 
Net Interest Income (+$)
Interest Income17,314
Interest Expense--
Other Finance Cost-0
Net Interest Income17,314
 
Pretax Income (+$)
Operating Income-4,712
Net Interest Income17,314
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-8,74416,634
EBIT - interestExpense = 0
-6,088
-6,088
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--8,744
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-8,744
Tax Provision--2,656
Net Income From Continuing Ops-6,088-6,088
Net Income-6,088
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-21,346-17,314
 

Technical Analysis of Axonics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Axonics. The general trend of Axonics is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Axonics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Axonics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 63.50 < 63.50 < 63.50.

The bearish price targets are: 61.50 > 61.50 > 60.50.

Tweet this
Axonics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Axonics Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Axonics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Axonics Inc. The current macd is 0.30634352.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Axonics price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Axonics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Axonics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Axonics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAxonics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Axonics Inc. The current adx is 27.50.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Axonics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Axonics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Axonics Inc. The current sar is 58.76.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Axonics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Axonics Inc. The current rsi is 57.90. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Axonics Inc Daily Relative Strength Index (RSI) ChartAxonics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Axonics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 1/(-6 +6).

  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Axonics price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Axonics Inc Daily Stochastic Oscillator ChartAxonics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Axonics Inc. The current cci is 3.14465409.

Axonics Inc Daily Commodity Channel Index (CCI) ChartAxonics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Axonics Inc. The current cmo is 15.19.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Axonics Inc Daily Chande Momentum Oscillator (CMO) ChartAxonics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Axonics Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Axonics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Axonics Inc Daily Williams %R ChartAxonics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Axonics Inc.

Axonics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Axonics Inc. The current atr is 0.48520895.

Axonics Inc Daily Average True Range (ATR) ChartAxonics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Axonics Inc. The current obv is 1,659.

Axonics Inc Daily On-Balance Volume (OBV) ChartAxonics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Axonics Inc. The current mfi is 50.13.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Axonics Inc Daily Money Flow Index (MFI) ChartAxonics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Axonics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-15 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-05 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06 00:00:00MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-27 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07 00:00:00CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Axonics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Axonics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.896
Ma 20Greater thanMa 5062.350
Ma 50Greater thanMa 10061.860
Ma 100Greater thanMa 20057.070
OpenGreater thanClose62.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Axonics with someone you think should read this too:
  • Are you bullish or bearish on Axonics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Axonics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Axonics Inc

I send you an email if I find something interesting about Axonics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Axonics Inc.

Receive notifications about Axonics Inc in your mailbox!